Lipid risk factors vary in prediction of risk for major coronary events in statin treated patients

被引：0
|
作者：
Holme, I.
Faergeman, O.
Kastelein, J. J. P.
Larsen, M. L.
Olsson, A. G.
Tikkanen, M. J.
Lindahl, C.
Cater, N.
Pedersen, T. R.
机构：
来源：
EUROPEAN HEART JOURNAL | 2007年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：731 / 732
页数：2
相关论文
共 50 条
  • [1] Lipid risk factors for vascular events in statin-treated diabetic coronary patients
    Drexel, Heinz
    Aczel, Stefan
    Marte, Thomas
    Schmid, Fabian
    Koch, Lorena
    Langer, Peter
    Rein, Philipp
    Hoefle, Guenter
    Saely, Christoph H.
    [J]. DIABETES, 2007, 56 : A180 - A180
  • [2] MAJOR ADVERSE CARDIOVASCULAR EVENTS: RISK FACTORS IN PATIENTS WITH RA TREATED WITH TOFACITINIB
    Charles-Schoeman, C.
    Valdez, H.
    Soma, K.
    Hwang, L.
    DeMasi, R.
    Boy, M.
    McInnes, I. B.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 1034 - 1035
  • [3] Major Adverse Cardiovascular Events: Risk Factors in Patients with RA Treated with Tofacitinib
    Charles-Schoeman, Christina
    Valdez, Hernan
    Soma, Koshika
    Hwang, Lie-Ju
    DeMasi, Ryan
    Boy, Mary
    McInnes, Iain B.
    [J]. ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [4] PROGNOSTIC MODEL OF RESIDUAL RISK FOR MAJOR CARDIOVASCULAR EVENTS IN STATIN-TREATED CORONARY PATIENTS: A COMBINED ANALYSIS OF THE IDEAL AND TNT TRIALS
    Holme, Ingar
    Faergeman, Ole
    Fayyad, Rana
    Wun, Chuan-Chuan
    Kastelein, John
    Olsson, Anders
    Tikkanen, Matti
    Larsen, Mogens
    Lindahl, Christina
    Pedersen, Terje
    Boekholdt, Matthijs
    Wenger, Nanette
    Barter, Phillip
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 59 (13) : E1495 - E1495
  • [5] Statin adherence and the risk of major coronary events in patients with diabetes: a nested case-control study
    Ruokoniemi, Paivi
    Korhonen, Maarit J.
    Helin-Salmivaara, Arja
    Lavikainen, Piia
    Jula, Antti
    Junnila, Seppo Y. T.
    Kettunen, Raimo
    Huupponen, Risto
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 71 (05) : 766 - 776
  • [6] Obesity and adipokines as risk factors for major coronary heart disease events in patients with CHD: Results from the lipid trial
    Colquhoun, D.
    Soderberg, S.
    Kirby, A.
    Keech, A.
    Simes, J.
    Hague, W.
    Hamilton-Craig, I.
    Tonkin, A.
    [J]. ATHEROSCLEROSIS SUPPLEMENTS, 2006, 7 (03) : 330 - 330
  • [7] Lipid predictors of cardiovascular events in statin-treated coronary patients with diabetes mellitus
    Drexel, H.
    Aczel, S.
    Marte, T.
    Vonbank, A.
    Saely, C. H.
    [J]. DIABETOLOGIA, 2008, 51 : S548 - S548
  • [8] Combination of coronary CT angiography, FFRCT, and risk factors in the prediction of major adverse cardiovascular events in patients suspected CAD
    Wada, Shinichi
    Iwanaga, Yoshitaka
    Nakai, Michikazu
    Nakao, Yoko M.
    Miyamoto, Yoshihiro
    Noguchi, Teruo
    NADESICO Study Investigators
    [J]. CLINICAL CARDIOLOGY, 2023, 46 (05) : 494 - 501
  • [9] RISK FACTORS FOR MAJOR ADVERSE CARDIOVASCULAR EVENTS IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH TOCILIZUMAB
    Rao, Vijay
    Pavlov, Andrey
    Klearman, Micki
    Musselman, Dave
    Giles, Jon
    Bathon, Joan
    Sattar, Naveed
    Lee, Janet
    [J]. RHEUMATOLOGY, 2012, 51 : 138 - 138
  • [10] Risk Factors for Major Adverse Cardiovascular Events in Rheumatoid Arthritis Patients Treated with Tocilizumab
    Rao, Vijay
    Pavlov, Andrey
    Klearman, Micki
    Musselman, David
    Giles, Jon T.
    Bathon, Joan M.
    Sattar, Naveed
    Lee, Janet S.
    [J]. ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S642 - S642
12345